Like the Ipamorelin + CJC-1295 blend, this combination exploits the well-characterized synergy between GHRH and GHSR signaling pathways at the pituitary
Here are the details
(PDF) Webb, E.K., Stevens, J.S., Ely, T.D., Lebois, L.A.M., van Rooij, S.J.H., Bruce, S.E., House, S.L., Beaudoin, F.L., An, X., Neylan, T.C., Clifford, G.D., Linnstaedt, S.D., Germine, L.T., Bollen, K.A., Rauch, S.L., Haran, J.P., Storrow, A.B., Lewandowski, C., Musey, P.I., Hendry, P.H., Sheikh, S., Jones, C.W., Punches, B.E., Swor, R.A., Murty, V.P., Hudak, L.A., Pascual, J.L., Seamon, M.J., Datner, E.M., Pearson, C., Peak, D.A., Domeier, R.M., Rathlev, N.K., ONeil, B.J., Sergot, P., Sanchez, L.D., Joormann, J., Pizzagalli, D.A., Harte, S.E., Kessler, R.C., Koenen, K.C., Ressler, K.J., McLean, S.A., Harnett, N.G
Houston Methodist Hospital and Houston Research Institute, Houston (M.N.), and the Texas Liver Institute, University of Texas Health San Antonio, San Antonio (E.L
Food and Drug Administration (2023) Hany Demian, MD of BioSpine Institute Rasoul Montazeri, DO of Healthon Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice